HEADER CELL ADHESION 11-DEC-08 2W5P TITLE DRAE ADHESIN IN COMPLEX WITH CHLORAMPHENICOL SUCCINATE ( TITLE 2 MONOCLINIC FORM) COMPND MOL_ID: 1; COMPND 2 MOLECULE: DR HEMAGGLUTININ STRUCTURAL SUBUNIT; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: ADHESIN SUBUNIT, RESIDUES 23-160; COMPND 5 SYNONYM: DRAE HAEMAGGLUTININ; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 STRAIN: IH11128; SOURCE 5 VARIANT: O75\:K5\:H; SOURCE 6 CELL_LINE: M15; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PQE-30 KEYWDS UPEC, DRAE, DAEC, ADHESIN, FIMBRIUM, HAEMAGGLUTININ, CELL KEYWDS 2 PROJECTION, FIMBRIAL ADHESIN, CHLORAMPHENICOL SUCCINATE, KEYWDS 3 CELL ADHESION EXPDTA X-RAY DIFFRACTION AUTHOR D.M.PETTIGREW,P.ROVERSI,S.G.DAVIES,A.J.RUSSELL,S.M.LEA REVDAT 1 02-JUN-09 2W5P 0 JRNL AUTH D.M.PETTIGREW,P.ROVERSI,S.G.DAVIES,A.J.RUSSELL, JRNL AUTH 2 S.M.LEA JRNL TITL A STRUCTURAL STUDY OF THE INTERACTION BETWEEN THE JRNL TITL 2 DR HAEMAGGLUTININ DRAE AND DERIVATIVES OF JRNL TITL 3 CHLORAMPHENICOL JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 65 513 2009 JRNL REFN ISSN 0907-4449 JRNL PMID 19465765 JRNL DOI 10.1107/S0907444909005113 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER/TNT REMARK 3 AUTHORS : BLANC,ROVERSI,VONRHEIN,BRICOGNE,TRONRUD, REMARK 3 : TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 34784 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1747 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.00 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.10 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 5228 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1950 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4957 REMARK 3 BIN R VALUE (WORKING SET) : 0.1930 REMARK 3 BIN FREE R VALUE : 0.2370 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 271 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3200 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 345 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 1.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.40000 REMARK 3 B22 (A**2) : 1.20000 REMARK 3 B33 (A**2) : -3.50000 REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : -0.45000 REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 1.50 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : NULL ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. STRUCTURE REFINED WITH NO NCS ALTHOUGH IT REMARK 3 CONTAINS THREE COPIES OF THE SAME PROTEIN. THE NCS WAS NOT REMARK 3 ENFORCED REMARK 4 REMARK 4 2W5P COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-DEC-08. REMARK 100 THE PDBE ID CODE IS EBI-38304. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-DEC-04 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.931 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34784 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.90 REMARK 200 RESOLUTION RANGE LOW (A) : 59.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 200 DATA REDUNDANCY : 4.1 REMARK 200 R MERGE (I) : 0.10 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.00 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.0 REMARK 200 R MERGE FOR SHELL (I) : 0.38 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.00 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1USQ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.2 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: (NH4)2SO4 2M, 10 MM REMARK 280 CHLORAMPHENICOL SUCCINATE, 0.1 M NAHEPES PH 7.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 59.47050 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.27650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 59.47050 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.27650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 4590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLU 39 TO LYS REMARK 400 ENGINEERED RESIDUE IN CHAIN B, GLU 39 TO LYS REMARK 400 ENGINEERED RESIDUE IN CHAIN C, GLU 39 TO LYS REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A -9 REMARK 465 GLY A -8 REMARK 465 SER A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 ARG B -9 REMARK 465 GLY B -8 REMARK 465 SER B -7 REMARK 465 HIS B -6 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 HIS B -3 REMARK 465 HIS B -2 REMARK 465 HIS B -1 REMARK 465 ARG C -9 REMARK 465 GLY C -8 REMARK 465 SER C -7 REMARK 465 HIS C -6 REMARK 465 HIS C -5 REMARK 465 HIS C -4 REMARK 465 HIS C -3 REMARK 465 HIS C -2 REMARK 465 HIS C -1 REMARK 465 GLN C 67 REMARK 465 GLY C 68 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLN A 67 N - CA - C ANGL. DEV. = 17.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 5 83.22 -165.63 REMARK 500 ALA A 38 -3.18 77.81 REMARK 500 GLN A 67 125.58 17.76 REMARK 500 SER B 5 87.50 -166.27 REMARK 500 GLN B 67 128.16 18.75 REMARK 500 ARG B 78 -62.33 -124.54 REMARK 500 GLN B 120 48.01 -146.46 REMARK 500 SER C 5 84.43 -164.02 REMARK 500 ALA C 38 -0.98 75.12 REMARK 500 ASN C 77 54.03 -108.33 REMARK 500 ARG C 78 -60.51 -122.68 REMARK 500 GLN C 120 51.33 -144.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLU B 66 13.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 GLN A 67 9.2 L D EXPECTING SP3 REMARK 500 LYS A 139 23.9 L L OUTSIDE RANGE REMARK 500 GLN B 67 19.7 L L OUTSIDE RANGE REMARK 500 ASN C 77 21.5 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 CL8 A 143 REMARK 610 CL8 B 143 REMARK 610 CL8 C 143 REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL8 A 143 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 159 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL8 B 143 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 159 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL8 C 143 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 159 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1USQ RELATED DB: PDB REMARK 900 COMPLEX OF E. COLI DRAE ADHESIN WITH REMARK 900 CHLORAMPHENICOL REMARK 900 RELATED ID: 1UT1 RELATED DB: PDB REMARK 900 DRAE ADHESIN FROM ESCHERICHIA COLI REMARK 900 RELATED ID: 2JKL RELATED DB: PDB REMARK 900 DRAE ADHESIN IN COMPLEX WITH BROMAMPHENICOL REMARK 900 RELATED ID: 2JKJ RELATED DB: PDB REMARK 900 DRAE ADHESIN IN COMPLEX WITH CHLORAMPHENICOL REMARK 900 SUCCINATE REMARK 900 RELATED ID: 2JKN RELATED DB: PDB REMARK 900 DRAE ADHESIN IN COMPLEX WITH CHLORAMPHENICOL REMARK 900 SUCCINATE (TRIGONAL FORM) REMARK 999 REMARK 999 SEQUENCE REMARK 999 E18K DBREF 2W5P A -9 1 PDB 2W5P 2W5P -9 1 DBREF 2W5P A 2 139 UNP P24093 DRAA_ECOLX 23 160 DBREF 2W5P B -9 1 PDB 2W5P 2W5P -9 1 DBREF 2W5P B 2 139 UNP P24093 DRAA_ECOLX 23 160 DBREF 2W5P C -9 1 PDB 2W5P 2W5P -9 1 DBREF 2W5P C 2 139 UNP P24093 DRAA_ECOLX 23 160 SEQADV 2W5P LYS A 18 UNP P24093 GLU 39 ENGINEERED MUTATION SEQADV 2W5P LYS B 18 UNP P24093 GLU 39 ENGINEERED MUTATION SEQADV 2W5P LYS C 18 UNP P24093 GLU 39 ENGINEERED MUTATION SEQRES 1 A 149 ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER PHE THR SEQRES 2 A 149 PRO SER GLY THR THR GLY THR THR LYS LEU THR VAL THR SEQRES 3 A 149 GLU LYS CYS GLN VAL ARG VAL GLY ASP LEU THR VAL ALA SEQRES 4 A 149 LYS THR ARG GLY GLN LEU THR ASP ALA ALA PRO ILE GLY SEQRES 5 A 149 PRO VAL THR VAL GLN ALA LEU GLY CYS ASP ALA ARG GLN SEQRES 6 A 149 VAL ALA LEU LYS ALA ASP THR ASP ASN PHE GLU GLN GLY SEQRES 7 A 149 LYS PHE PHE LEU ILE SER ASP ASN ASN ARG ASP LYS LEU SEQRES 8 A 149 TYR VAL ASN ILE ARG PRO THR ASP ASN SER ALA TRP THR SEQRES 9 A 149 THR ASP ASN GLY VAL PHE TYR LYS ASN ASP VAL GLY SER SEQRES 10 A 149 TRP GLY GLY ILE ILE GLY ILE TYR VAL ASP GLY GLN GLN SEQRES 11 A 149 THR ASN THR PRO PRO GLY ASN TYR THR LEU THR LEU THR SEQRES 12 A 149 GLY GLY TYR TRP ALA LYS SEQRES 1 B 149 ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER PHE THR SEQRES 2 B 149 PRO SER GLY THR THR GLY THR THR LYS LEU THR VAL THR SEQRES 3 B 149 GLU LYS CYS GLN VAL ARG VAL GLY ASP LEU THR VAL ALA SEQRES 4 B 149 LYS THR ARG GLY GLN LEU THR ASP ALA ALA PRO ILE GLY SEQRES 5 B 149 PRO VAL THR VAL GLN ALA LEU GLY CYS ASP ALA ARG GLN SEQRES 6 B 149 VAL ALA LEU LYS ALA ASP THR ASP ASN PHE GLU GLN GLY SEQRES 7 B 149 LYS PHE PHE LEU ILE SER ASP ASN ASN ARG ASP LYS LEU SEQRES 8 B 149 TYR VAL ASN ILE ARG PRO THR ASP ASN SER ALA TRP THR SEQRES 9 B 149 THR ASP ASN GLY VAL PHE TYR LYS ASN ASP VAL GLY SER SEQRES 10 B 149 TRP GLY GLY ILE ILE GLY ILE TYR VAL ASP GLY GLN GLN SEQRES 11 B 149 THR ASN THR PRO PRO GLY ASN TYR THR LEU THR LEU THR SEQRES 12 B 149 GLY GLY TYR TRP ALA LYS SEQRES 1 C 149 ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER PHE THR SEQRES 2 C 149 PRO SER GLY THR THR GLY THR THR LYS LEU THR VAL THR SEQRES 3 C 149 GLU LYS CYS GLN VAL ARG VAL GLY ASP LEU THR VAL ALA SEQRES 4 C 149 LYS THR ARG GLY GLN LEU THR ASP ALA ALA PRO ILE GLY SEQRES 5 C 149 PRO VAL THR VAL GLN ALA LEU GLY CYS ASP ALA ARG GLN SEQRES 6 C 149 VAL ALA LEU LYS ALA ASP THR ASP ASN PHE GLU GLN GLY SEQRES 7 C 149 LYS PHE PHE LEU ILE SER ASP ASN ASN ARG ASP LYS LEU SEQRES 8 C 149 TYR VAL ASN ILE ARG PRO THR ASP ASN SER ALA TRP THR SEQRES 9 C 149 THR ASP ASN GLY VAL PHE TYR LYS ASN ASP VAL GLY SER SEQRES 10 C 149 TRP GLY GLY ILE ILE GLY ILE TYR VAL ASP GLY GLN GLN SEQRES 11 C 149 THR ASN THR PRO PRO GLY ASN TYR THR LEU THR LEU THR SEQRES 12 C 149 GLY GLY TYR TRP ALA LYS HET CL8 A 143 6 HET SO4 A 159 5 HET CL8 B 143 6 HET SO4 B 159 5 HET CL8 C 143 6 HET SO4 C 159 5 HETNAM SO4 SULFATE ION HETNAM CL8 CHLORAMPHENICOL SUCCINATE FORMUL 4 SO4 3(O4 S 2-) FORMUL 5 CL8 3(C15 H16 N2 O8 CL2) FORMUL 6 HOH *345(H2 O1) HELIX 1 1 GLY A 33 LEU A 35 5 3 HELIX 2 2 GLY B 33 LEU B 35 5 3 HELIX 3 3 GLY C 33 LEU C 35 5 3 HELIX 4 4 THR C 62 ASN C 64 5 3 SHEET 1 AA 3 ALA A 29 THR A 31 0 SHEET 2 AA 3 SER A 1 THR A 16 1 O THR A 14 N LYS A 30 SHEET 3 AA 3 GLY A 126 ALA A 138 -1 O GLY A 126 N VAL A 15 SHEET 1 AB 7 ALA A 29 THR A 31 0 SHEET 2 AB 7 SER A 1 THR A 16 1 O THR A 14 N LYS A 30 SHEET 3 AB 7 GLN B 20 VAL B 23 1 O VAL B 21 N THR A 7 SHEET 4 AB 7 PRO A 40 LEU A 49 -1 O GLN A 47 N ARG B 22 SHEET 5 AB 7 GLY A 109 VAL A 116 -1 O GLY A 110 N VAL A 46 SHEET 6 AB 7 LYS A 80 PRO A 87 -1 O ASN A 84 N TYR A 115 SHEET 7 AB 7 LYS A 69 SER A 74 -1 O PHE A 70 N VAL A 83 SHEET 1 CA 8 ALA C 29 THR C 31 0 SHEET 2 CA 8 SER C 1 THR C 16 1 O THR C 14 N LYS C 30 SHEET 3 CA 8 GLN A 20 VAL A 23 1 O VAL A 21 N THR C 7 SHEET 4 CA 8 PRO C 40 LEU C 49 -1 O GLN C 47 N ARG A 22 SHEET 5 CA 8 GLY C 109 VAL C 116 -1 O GLY C 110 N VAL C 46 SHEET 6 CA 8 LYS C 80 PRO C 87 -1 O ASN C 84 N TYR C 115 SHEET 7 CA 8 PHE C 70 SER C 74 -1 O PHE C 70 N VAL C 83 SHEET 8 CA 8 GLY C 126 ALA C 138 -1 O THR C 129 N ILE C 73 SHEET 1 CB 3 ALA C 29 THR C 31 0 SHEET 2 CB 3 SER C 1 THR C 16 1 O THR C 14 N LYS C 30 SHEET 3 CB 3 GLY C 126 ALA C 138 -1 O GLY C 126 N VAL C 15 SHEET 1 BA 3 ALA B 29 THR B 31 0 SHEET 2 BA 3 SER B 1 THR B 16 1 O THR B 14 N LYS B 30 SHEET 3 BA 3 GLY B 126 ALA B 138 -1 O GLY B 126 N VAL B 15 SHEET 1 BB 7 ALA B 29 THR B 31 0 SHEET 2 BB 7 SER B 1 THR B 16 1 O THR B 14 N LYS B 30 SHEET 3 BB 7 GLN C 20 VAL C 23 1 O VAL C 21 N THR B 7 SHEET 4 BB 7 PRO B 40 LEU B 49 -1 O GLN B 47 N ARG C 22 SHEET 5 BB 7 GLY B 109 VAL B 116 -1 O GLY B 110 N VAL B 46 SHEET 6 BB 7 LYS B 80 PRO B 87 -1 O ASN B 84 N TYR B 115 SHEET 7 BB 7 LYS B 69 SER B 74 -1 O PHE B 70 N VAL B 83 SSBOND 1 CYS A 19 CYS C 51 1555 1555 2.03 SSBOND 2 CYS A 51 CYS B 19 1555 1555 2.03 SSBOND 3 CYS B 51 CYS C 19 1555 1555 2.03 CISPEP 1 ALA A 138 LYS A 139 0 6.22 CISPEP 2 ALA B 138 LYS B 139 0 1.00 SITE 1 AC1 5 PRO A 40 GLY A 42 GLY A 113 ILE A 114 SITE 2 AC1 5 TYR A 115 SITE 1 AC2 7 GLY A 24 ASP A 25 HOH A2114 HOH A2115 SITE 2 AC2 7 THR C 8 GLY C 9 THR C 10 SITE 1 AC3 6 PRO B 40 GLY B 42 PRO B 43 GLY B 113 SITE 2 AC3 6 ILE B 114 TYR B 115 SITE 1 AC4 6 THR A 8 GLY A 9 THR A 10 GLY B 24 SITE 2 AC4 6 ASP B 25 HOH B2022 SITE 1 AC5 6 PRO C 40 GLY C 42 PRO C 43 GLY C 113 SITE 2 AC5 6 ILE C 114 TYR C 115 SITE 1 AC6 5 GLY B 9 THR B 10 GLY C 24 ASP C 25 SITE 2 AC6 5 HOH C2118 CRYST1 118.941 68.553 62.061 90.00 111.17 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008408 0.000000 0.003256 0.00000 SCALE2 0.000000 0.014587 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017279 0.00000 MASTER 384 0 6 4 31 0 12 6 0 0 0 36 END